Telemonitoring Heart Failure Patients Does Not Significantly Lower All-Cause Readmission and Mortality Rates
Results from the BEAT-HF study showed a lack of significant reduction in readmission and mortality for heart failure patients.
Results from the BEAT-HF study showed a lack of significant reduction in readmission and mortality for heart failure patients.
NT-proBNP levels were not significantly affected by vericiguat, a soluble guanylate cyclase stimulator, in patients with chronic heart failure and reduced LVEF.
Polymer-free drug-coated stent demonstrated superiority vs bare-metal stent when used in conjunction with DAPT.
Results from the ISAR-DESIRE 4 clinical trial indicate that use of scoring balloon plus a paclitaxel-coated balloon was angiographically superior compared with drug-coated balloon alone.
IN.PACT SFA trial results reveal that drug-coated balloons demonstrate significantly higher primary patency compared with percutaneous transluminal angioplasty for patients with peripheral artery disease.
Women with BMIs in the overweight range had lower all-cause mortality than men within the same range.
Ten new genes have been found to be associated with coronary artery disease susceptibility.